We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased...
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence...
Smith & Nephew Plc 02 April 2024 2 April 2024 Voting Rights and Capital In conformity with Rule 5.6 of the FCA's Disclosure and Transparency Rules:- The total issued share...
Smith & Nephew Plc 02 April 2024 SMITH & NEPHEW PLC 2 April 2024 NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF...
Smith & Nephew PLC on Thursday confirmed that incoming Chief Financial Officer John Rogers will officially start the ...
Smith & Nephew Plc 28 March 2024 28 March 2024 SMITH & NEPHEW PLC Notification under Listing Rule 9.6.12...
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been...
C - Watford, England-based medical devices maker - Prices USD350.0 million in 3-year debt notes due 2027 with 5.15% co ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -25 | -2.53344142683 | 986.8 | 991 | 946 | 3889146 | 962.81204746 | DE |
4 | -72.2 | -6.98259187621 | 1034 | 1050 | 946 | 4025155 | 980.68060453 | DE |
12 | -129.7 | -11.8827301878 | 1091.5 | 1181.5 | 946 | 3466783 | 1048.37122247 | DE |
26 | 31 | 3.33046841427 | 930.8 | 1181.5 | 887 | 3144942 | 1036.04319663 | DE |
52 | -235.7 | -19.6826722338 | 1197.5 | 1316 | 887 | 2959406 | 1087.65861945 | DE |
156 | -488.2 | -33.6689655172 | 1450 | 1601.5 | 887 | 2723643 | 1179.18325244 | DE |
260 | -484.7 | -33.5084687176 | 1446.5 | 2023 | 887 | 2564809 | 1337.25768472 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions